Welcome to LookChem.com Sign In|Join Free

CAS

  • or

130610-93-4

Post Buying Request

130610-93-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

130610-93-4 Usage

Uses

Niravoline (CAS# 130610-93-4) is a selective kappa–opioid receptor agonist in the treatment of intracranial hypertension.

Check Digit Verification of cas no

The CAS Registry Mumber 130610-93-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,6,1 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 130610-93:
(8*1)+(7*3)+(6*0)+(5*6)+(4*1)+(3*0)+(2*9)+(1*3)=84
84 % 10 = 4
So 130610-93-4 is a valid CAS Registry Number.
InChI:InChI=1/C22H25N3O3/c1-23(21(26)14-16-7-6-9-18(13-16)25(27)28)22-19-10-3-2-8-17(19)15-20(22)24-11-4-5-12-24/h2-3,6-10,13,20,22H,4-5,11-12,14-15H2,1H3/t20-,22?/m0/s1

130610-93-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Methyl-2-(3-nitrophenyl)-N-[(1S,2S)-2-(1-pyrrolidinyl)-2,3-dihy dro-1H-inden-1-yl]acetamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:130610-93-4 SDS

130610-93-4Upstream product

130610-93-4Downstream Products

130610-93-4Relevant articles and documents

Indanes useful as analgesics

-

, (2008/06/13)

Novel indanes in all possible stereoisomer forms of the formula STR1 wherein the substrates are as defined in the application and their non-toxic, pharmaceutically acceptable acid addition salts and their hydrates are disclosed as having central analgesic

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 130610-93-4